Home > PB Ratio > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
PB (Price/Book ) Ratio

The Current P/B Ratio of SAMRAT PHARMACHEM is 1.79.

Share Price ₹375.7Dec 26,2024
Market Cap ₹116.5 Cr
Book Value₹65.0 CrMar2024 - Standalone Results
Price/Book 1.79xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results
SAMRAT PHARMACHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of SAMRAT PHARMACHEM

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of SAMRAT PHARMACHEM is calculated as :

Current Market Cap [ ₹116.5 Cr] as on Dec 26,2024

(/) Book Value [ ₹65.0 Cr] based on Mar2024 - Standalone Results

(=) P/B Ratio [ 1.79x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for SAMRAT PHARMACHEM , the investors are currently willing to pay '1.79 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SAMRAT PHARMACHEM !

The chart below summarizes the trend in P/B Ratio of SAMRAT PHARMACHEM over the last five years.

Historical PB (Price/Book ) ratio chart of SAMRAT PHARMACHEM


PB Ratio Performance Analysis for SAMRAT PHARMACHEM

- SAMRAT PHARMACHEM 's latest p/b ratio is 1.79x.

- SAMRAT PHARMACHEM 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.76x.

- SAMRAT PHARMACHEM 's operated at median p/b ratio of 1.59x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SAMRAT PHARMACHEM 's p/b ratio peaked in Mar2022 at 3.2x.

- SAMRAT PHARMACHEM 's p/b ratio hit its five-year low in Mar2020 of 0.76x.


How does SAMRAT PHARMACHEM 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
SAMRAT PHARMACHEM 65.001.79116.5
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.94441,838.0
CIPLA LTD26,619.904.52120,270.0
DR REDDYS LABORATORIES LTD28,123.504.02113,077.0
ZYDUS LIFESCIENCES LTD19,829.504.8796,553.2
DIVIS LABORATORIES LTD13,571.0011.50156,107.0
MANKIND PHARMA LTD9,339.8412.87120,212.0
TORRENT PHARMACEUTICALS LTD6,856.1516.87115,643.0
LUPIN LTD14,175.807.0299,532.1
AUROBINDO PHARMA LTD29,842.802.4472,945.8
ABBOTT INDIA LTD3,658.7316.6360,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SAMRAT PHARMACHEM 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 1.79x
Max industry PB 16.87x
Median industry PB 6.94x
Average industry PB 8.13x



You may also like the below Video Courses